What do you do after you have launched a spinout that has raised venture capital from illustrious backers such as pharmaceutical firm Novo, care provider Kaiser Permanente and medical device manufacturer St Jude Medical, and successfully gone public through a $107m initial public offering?
You do it again, of course.
Uday Kumar, an adjunct professor in bioengineering at Stanford University, may sound familiar if you have been reading Global University Venturing for a while: his previous venture, arrhythmia diagnostics technology producer iRhythm Technologies, won the GUV Award for Exit of the Year in 2017.
That spinout, founded in 2006, collected $112m in equity financing before going public and has only gone from strength to strength since then: both in terms of commercial successes –…
Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
